Lilly, a medicine company, agreed to acquire Pleasant Prairie facility from Nexus Pharmaceuticals, a pharmaceutical company. Financial terms were not disclosed. “The acquisition of this state-of-the-art facility underscores our unwavering commitment to growth and innovation, and we look forward to welcoming talented new Nexus colleagues to Lilly from the Pleasant Prairie facility. We are investing boldly to serve our patients, to meet product demand and to build capabilities for our robust pipeline of the future," Edgardo Hernandez, Lilly Executive Vice President.